Table 2.
Demographic, clinical, laboratory, and coronary angiographic characteristics of patients with and without NOAF with p value in matched population
| Patients without NOAF (n = 84) | Patients with NOAF (n = 86) | p Value | |
|---|---|---|---|
| Age (years) | 59 ± 12 | 63 ± 12 | .015 |
| Male n (%) | 63 (81.8) | 63 (73.3) | .193 |
| Hypertension n (%) | 49 (63.6) | 54 (62.8) | .911 |
| DM n (%) | 26 (33.8) | 34 (39.5) | .446 |
| COPD n (%) | 5 (6.5) | 7 (8.1) | .688 |
| PAD n (%) | 19 (24.7) | 22 (25.6) | .894 |
| Dyslipidemia n (%) | 34 (44.2) | 31 (36) | .291 |
| Smoking n (%) | 35 (45.5) | 29 (33.7) | .126 |
| Killip class > 1 on admission n (%) | 24 (31.2) | 33 (38.4) | .336 |
| SBP (mm Hg) | 139 ± 41 | 133 ± 40 | .321 |
| Heart rate (bpm) | 78 ± 19 | 81 ± 19 | .365 |
| eGFR (ml/min) | 86 ± 29 | 77 ± 28 | .506 |
| WBC count (103/μl) | 13.3 ± 4.3 | 13.8 ± 4.4 | .265 |
| Hemoglobin (g/dl) | 13.5 ± 1.9 | 13.2 ± 2.1 | .097 |
| Peak CK‐MB (U/L) | 241 (102–398) | 344 (187–430) | .405 |
| Peak troponin I (ng/ml) | 108 (47–216) | 165 (87–253) | .081 |
| LVEF (%) | 44 ± 9 | 40 ± 8 | .005 |
| IRA (%) | |||
| LAD | 46 (59.7) | 48 (55.8) | .629 |
| Cx | 7 (9.1) | 7 (8.1) | |
| RCA | 23 (29.9) | 31 (36) | |
| Other | 1 (1.30) | 0 (0.0) | |
| LMCA disease (%) | 1 (1.3) | 0 (0) | .354 |
| Post‐pPCI TIMI grade <3 n (%) | 9 (11.1) | 22 (25.6) | .015 |
| Duration of telemetry monitoring (days) | 2.50 (1.50–3.50) | 3.00 (1.50–4.00) | .06 |
| SYNTAX score | 16.7 ± 3.6 | 18.6 ± 4 | .002 |
| SYNTAX score II | 35.1 ± 13.1 | 42 ± 13.4 | .001 |
DM, diabetes mellitus; COPD, chronic obstructive pulmonary disease; PAD, peripheral artery disease; SBP, systolic blood pressure; eGFR, estimated glomerular filtration rate; WBC, white blood cell; CK‐MB, creatine kinase‐myocardial band; LVEF, left ventricular ejection fraction; IRA, infarct related artery; LAD, left anterior descending; Cx, circumflex; RCA, right coronary artery; LMCA, left main coronary artery; SYNTAX, Synergy between PCI with Taxus and Cardiac Surgery; NOAF, new‐onset atrial fibrillation.